Terms and conditions
Click on the expandable area below to view the terms and conditions referred to in the text of the purchase order or tender document you have received.
Brazil
Canada
China
Denmark
Finland
France
Germany
Italy
Japan
Mexico
Norway
Puerto Rico
Spain
Sweden
UK
US
Current
Notice of Legal Entity Change – December 28, 2016 (PDF 304kb)
General Terms and Conditions – US – 01/2023 (PDF 304kb)
US Sunshine Act / Open Payment Data Requirements (PDF 99kb)
Previous
General Terms and Conditions (Valid 08/04/2021) (PDF 232kb)
General Terms and Conditions (Valid 15/11/2019) (PDF 205kb)
General Terms and Conditions (Valid 12/05/2016) (PDF 218kb)
General Terms and Conditions (Valid 08/18/2014) (PDF 603kb)
General Terms and Conditions (Valid 06/04/2014) (PDF 478kb)
General Terms and Conditions (Valid 12/05/2012) (PDF 100kb)
General Terms and Conditions (Valid 1/30/2012) (PDF 529kb)
General Terms and Conditions (Valid 9/10/2010) (PDF 299kb)
General Terms and Conditions (Valid 9/05/2009) (PDF 119kb)
Important, please note:
- For information on AstraZeneca’s purchase order and invoicing processes, including where to send invoices and how to get help, please see our Supplier Information pages.
- If you require further assistance or if you are unsure as to which terms and conditions apply, contact the person named in the document you have received or your local AstraZeneca contact.
- If the reference for the terms and conditions on your order differs from the reference stated above please contact the person named on the purchase order to receive a copy of the correct document.
- The documents above are the copyright of AstraZeneca UK Ltd and/or its affiliates and must not be reproduced.
- These documents will be updated from time to time. If you print a hard copy for reference please refer to this site for the latest revisions for all future contracts.